NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Here's my issue Fear, most every biopharm company makes 60-70% of their revenue in the US. In the fist 2 years of a launch this is closer to 100% than it is 60% for certain. NWBO and Cognate have had sufficient capacity in the states to service the launch and could have built our European capacity as the prolonged process to EU marketing transpired. EMEA Approval is the first step in a long process to gaining access to EU markets that are far less profitable than the homeland. Fish where the fish are. That is what most every company does.

The idea that they leveraged literally hundreds of millions of shares (and thus diluting me several fold) in order to prepare European capacity pees me off. This may be a legal maneuver but it smells very fishy to me. Clearly a share grab. Shame!

I am allied to LP despite my distrust of this situation. I will chalk my truncated gain up as another market learning lesson. I am reminded again that the powerful play with a different deck of cards than I do and that just sucks. At least, I am certain I will profit handsomely regardless and at the same time I know that I helped make a positive I've impact on the world by doing so.